SPAC Winners & Losers SPACs Attack

Episode Summary:On Today's SPACs Attack Chris & Money Mitch get into The top-performing SPACs. Also, which have tanked? Find out on SPACs Attack.
Hosts:
Mitch Hoch
Twitter: https://twitter.com/STORYInvestors
Chris Katje
Twitter: https://twitter.com/chriskatje
For FASTER NEWS and IN-DEPTH market data, check out Benzinga Pro. For a free two-week trial go to http://pro.benzinga.com/register

Listen to SPACs Attack Archive here
Subscribe to all Benzinga Podcasts here
Sign up for the SPACs Attacks Newsletter here
Get 20% off Benzinga PRO https://benzinga.grsm.io/youtube20
Become a BENZINGA AFFILIATE and earn 30% on new subscriptions
Disclaimer: All of the information, material, and/or content contained in this program is for informational purposes only. Investing in stocks, options, and futures is risky and not suitable for all investors. Please consult your own independent financial adviser before making any investment decisions.
Unedited Transcript
What are traders? How are we doing out there? Hope you guys are ready for another specks attack. We have a great one. We're going to get into our headlines, our watch lists. We're going to get into some winners and losers. Then we'll talk about the calendar. What dates are coming up that you guys need to be informed on?

And of course, we'll get to some ticker time. Welcome to it. Specks attack hit the like let's get it started.

What's going on, everybody out there. Yes. I'm catching up with the chat. What's going on. Jason's blog. We are here. We are. We will see everything you put in that as comments. So if you're new to the show, definitely say hello, born to be free. Knows how we get it. Started smash the, like what? Spring on my man, Chris pedia.

What's up, man. What's going on brother? Yeah. How we doing? It's Wednesday. But for those of you out there who have not followed along with Benzinga TV this week, we will not have a show tomorrow or Friday because we have the wonderful Benzinga cannabis conference. Two days hybrid in-person New York and also live here on Benzinga.

So that means today will be our Friday show. I think Mitch, where we kind of do a little bit more casual, no interviews today. We're going to look at, we're going to take it back. We're going to do some headlines. We're going to talk about that deal. Announced. We're going to look at movers on our watch list.

We're going to take a peak at next week's calendar. As Mitch said, we're going to offer some trading ideas, some sectors to watch, and then we'll be taking your tickers from the chat like we normally do on a Friday. So again, a casual show here for those of you who are new to the show, um, I think you'll enjoy this one.

And for those of you who are normally here, you know, how we like to do on. All right, so I'm going to do something. I normally don't go out of the limb do in here, but I'm going to go ahead and say that we have over 170 people watching right now. If we get to a hundred likes today, I'll go ahead and take a trade live right here on the specs tech.

Of course, it's going to be more of a swing trade. I don't day trade specs. I don't think I've ever day traded a spec, but I can tell you right now, I don't mind taking a swing if you guys hit that, like I just might as well go ahead and do it. Let's go ahead. Let's get into our headlines first. I know that a lot of stocks are moving out there.

Some people are watching a stock that even, I didn't think would be up, but we'll talk about that. When we get to our watch list, first thing we do is get to our headlines and Chris do what do you do best and inform us, take us back.

All right guys. Yeah. Uh, let's talk headlines first here. So analysts notes out there. We have Jeffrey's initiating coverage on Sarcos technology. That's S T R C with a buy rating and a price target of $16. Our other big analysts note, this one was out yesterday. Um, I believe after the show aired was when I saw it.

Jasper therapeutics initiated, uh, by Oppenheimer